These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 28409488

  • 1. A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.
    Ooi QX, Wright DFB, Tait RC, Isbister GK, Duffull SB.
    Clin Pharmacokinet; 2017 Dec; 56(12):1555-1566. PubMed ID: 28409488
    [Abstract] [Full Text] [Related]

  • 2. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G, Legnani C.
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin].
    Yamamoto T, Hasegawa K, Onoda M, Tanaka K.
    Yakugaku Zasshi; 2016 Apr; 136(6):905-11. PubMed ID: 27252068
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A, Rao LV, Rapaport SI.
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [Abstract] [Full Text] [Related]

  • 5. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M.
    JPEN J Parenter Enteral Nutr; 2004 Nov; 28(6):388-98. PubMed ID: 15568285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic interactions between the novel calcium sensitiser levosimendan and warfarin.
    Antila S, Jarvinen A, Honkanen T, Lehtonen L.
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):705-10. PubMed ID: 11214780
    [Abstract] [Full Text] [Related]

  • 8. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK.
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [Abstract] [Full Text] [Related]

  • 9. Sodium dehydroacetate-induced disorder of coagulation function in broiler chickens and the protective effect afforded by vitamin K.
    Xu J, Hao F, Wang C, Zhao Z, Zhang M, Chen X, Zhang Y.
    Poult Sci; 2023 Mar; 102(3):102482. PubMed ID: 36706663
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients.
    Choonara IA, Scott AK, Haynes BP, Cholerton S, Breckenridge AM, Park BK.
    Br J Clin Pharmacol; 1985 Dec; 20(6):643-8. PubMed ID: 4091996
    [Abstract] [Full Text] [Related]

  • 12. Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.
    Chan E, Aarons L, Serlin M, Breckenridge A, Rowland M.
    Br J Clin Pharmacol; 1987 Nov; 24(5):621-5. PubMed ID: 3435692
    [Abstract] [Full Text] [Related]

  • 13. NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy.
    Takada T, Yamanashi Y, Konishi K, Yamamoto T, Toyoda Y, Masuo Y, Yamamoto H, Suzuki H.
    Sci Transl Med; 2015 Feb 18; 7(275):275ra23. PubMed ID: 25696002
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D, Fischer AM, Barre J, Pertuiset N, Dautzenberg MD, Jungers P, Houin G.
    Clin Nephrol; 1986 Feb 18; 25(2):75-80. PubMed ID: 3698349
    [Abstract] [Full Text] [Related]

  • 15. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
    Wallin R, Wajih N, Hutson SM.
    Vitam Horm; 2008 Feb 18; 78():227-46. PubMed ID: 18374197
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms of the factor VII gene associated with the low activities of vitamin K-dependent coagulation factors in one-month-old infants.
    Ito K, Goto K, Sugiura T, Muramatsu K, Ando T, Maniwa H, Yokoyama T, Sugiyama K, Togari H.
    Tohoku J Exp Med; 2007 Jan 18; 211(1):1-8. PubMed ID: 17202767
    [Abstract] [Full Text] [Related]

  • 17. Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation.
    Kuranari M, Hara M, Saikawa T, Kodama Y, Matsuo H, Sakata T, Takeyama M.
    J Clin Pharm Ther; 1997 Jan 18; 22(5-6):347-51. PubMed ID: 19160719
    [Abstract] [Full Text] [Related]

  • 18. Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
    Zeuthen EL, Lassen JF, Husted SE.
    Thromb Res; 2003 Mar 15; 109(5-6):241-6. PubMed ID: 12818245
    [Abstract] [Full Text] [Related]

  • 19. End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
    Mahaffey KW, Hellkamp AS, Patel MR, Hannan KL, Schwabe K, Nessel CC, Berkowitz SD, Halperin JL, Hankey GJ, Becker RC, Piccini JP, Breithardt G, Hacke W, Singer DE, Califf RM, Fox KA.
    Circ Cardiovasc Qual Outcomes; 2013 Jul 15; 6(4):470-8. PubMed ID: 23759472
    [Abstract] [Full Text] [Related]

  • 20. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R, Rawal A, Lee R, Shen YM, Frenkel EP.
    Br J Haematol; 2006 Mar 15; 132(5):604-7. PubMed ID: 16445834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.